We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · July 01, 2021

Erectile Function in Men With Diabetes Treated With Dulaglutide

The Lancet Diabetes & Endocrinology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Diabetes & Endocrinology
Erectile Function in Men With Type 2 Diabetes Treated With Dulaglutide: An Exploratory Analysis of the REWIND Placebo-Controlled Randomised Trial
Lancet Diabetes Endocrinol 2021 Jun 18;[EPub Ahead of Print], HS Bajaj, HC Gerstein, P Rao-Melacini, J Basile, H Colhoun, I Conget, WC Cushman, GR Dagenais, E Franek, M Hanefeld, M Keltai, M Lakshmanan, F Lanas, LA Leiter, P Lopez-Jaramillo, V Pirags, N Pogosova, J Probstfield, P Raubenheimer, L Ryden, JE Shaw, WH Sheu, D Xavier

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading